

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | cellular response to interleukin-15 (GO:0071350) | 6.11287022 |
| 2 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 5.96405108 |
| 3 | positive regulation of gamma-delta T cell activation (GO:0046645) | 5.92472193 |
| 4 | regulation of B cell receptor signaling pathway (GO:0050855) | 5.92333346 |
| 5 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 5.76614467 |
| 6 | negative regulation of cell killing (GO:0031342) | 5.76614467 |
| 7 | response to interleukin-15 (GO:0070672) | 5.76584532 |
| 8 | negative T cell selection (GO:0043383) | 5.68006941 |
| 9 | cytidine deamination (GO:0009972) | 5.58675580 |
| 10 | cytidine metabolic process (GO:0046087) | 5.58675580 |
| 11 | cytidine catabolic process (GO:0006216) | 5.58675580 |
| 12 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 5.45600216 |
| 13 | positive T cell selection (GO:0043368) | 5.31118073 |
| 14 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 5.22756490 |
| 15 | negative thymic T cell selection (GO:0045060) | 5.21354096 |
| 16 | positive thymic T cell selection (GO:0045059) | 5.18426227 |
| 17 | regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091 | 5.07344898 |
| 18 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 5.01146109 |
| 19 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.75590641 |
| 20 | regulation of gamma-delta T cell differentiation (GO:0045586) | 4.66497840 |
| 21 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.60662202 |
| 22 | DNA deamination (GO:0045006) | 4.54875641 |
| 23 | activated T cell proliferation (GO:0050798) | 4.52346514 |
| 24 | regulation of gamma-delta T cell activation (GO:0046643) | 4.46256600 |
| 25 | thymic T cell selection (GO:0045061) | 4.45349878 |
| 26 | T cell selection (GO:0045058) | 4.42258571 |
| 27 | mast cell activation involved in immune response (GO:0002279) | 4.27243620 |
| 28 | mast cell degranulation (GO:0043303) | 4.27243620 |
| 29 | mast cell activation (GO:0045576) | 4.27056645 |
| 30 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 4.26719712 |
| 31 | regulation of natural killer cell mediated immunity (GO:0002715) | 4.26719712 |
| 32 | negative regulation of T cell mediated immunity (GO:0002710) | 4.24285713 |
| 33 | negative regulation of T cell apoptotic process (GO:0070233) | 4.19195168 |
| 34 | positive regulation of B cell differentiation (GO:0045579) | 4.17421714 |
| 35 | T cell migration (GO:0072678) | 4.16854978 |
| 36 | regulation of B cell differentiation (GO:0045577) | 4.16570280 |
| 37 | positive regulation of granulocyte differentiation (GO:0030854) | 4.11256588 |
| 38 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 4.08299086 |
| 39 | regulation of leukocyte mediated cytotoxicity (GO:0001910) | 4.03458761 |
| 40 | regulation of T cell mediated cytotoxicity (GO:0001914) | 4.02733548 |
| 41 | positive regulation of leukocyte mediated cytotoxicity (GO:0001912) | 3.95970756 |
| 42 | positive regulation of natural killer cell mediated immunity (GO:0002717) | 3.93276641 |
| 43 | regulation of alpha-beta T cell proliferation (GO:0046640) | 3.92837315 |
| 44 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 3.89190572 |
| 45 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 3.87206533 |
| 46 | leukocyte aggregation (GO:0070486) | 3.75938270 |
| 47 | B cell receptor signaling pathway (GO:0050853) | 3.74385053 |
| 48 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.73390459 |
| 49 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 3.69810864 |
| 50 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.67274745 |
| 51 | regulation of cell killing (GO:0031341) | 3.66192187 |
| 52 | leukocyte degranulation (GO:0043299) | 3.65861380 |
| 53 | positive regulation of natural killer cell mediated cytotoxicity (GO:0045954) | 3.65498722 |
| 54 | immunoglobulin mediated immune response (GO:0016064) | 3.64600335 |
| 55 | antigen receptor-mediated signaling pathway (GO:0050851) | 3.57572971 |
| 56 | T cell receptor signaling pathway (GO:0050852) | 3.57081940 |
| 57 | positive regulation of cell killing (GO:0031343) | 3.55130608 |
| 58 | regulation of regulatory T cell differentiation (GO:0045589) | 3.53346078 |
| 59 | negative regulation of interleukin-12 production (GO:0032695) | 3.51941660 |
| 60 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.46794055 |
| 61 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 3.41182096 |
| 62 | cellular defense response (GO:0006968) | 3.38533089 |
| 63 | positive regulation of tolerance induction (GO:0002645) | 3.35960904 |
| 64 | actin nucleation (GO:0045010) | 3.35804555 |
| 65 | positive regulation of calcium-mediated signaling (GO:0050850) | 3.35754615 |
| 66 | regulation of T cell tolerance induction (GO:0002664) | 3.33581191 |
| 67 | positive regulation of defense response to virus by host (GO:0002230) | 3.30529949 |
| 68 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.21832126 |
| 69 | negative regulation of viral genome replication (GO:0045071) | 3.21176555 |
| 70 | B cell mediated immunity (GO:0019724) | 3.20740237 |
| 71 | interferon-gamma production (GO:0032609) | 3.20644115 |
| 72 | regulation of tolerance induction (GO:0002643) | 3.16202528 |
| 73 | NIK/NF-kappaB signaling (GO:0038061) | 3.14402624 |
| 74 | regulation of lymphocyte chemotaxis (GO:1901623) | 3.11060327 |
| 75 | regulation of T cell receptor signaling pathway (GO:0050856) | 3.08215061 |
| 76 | T cell costimulation (GO:0031295) | 3.07011492 |
| 77 | lymphocyte chemotaxis (GO:0048247) | 3.06353950 |
| 78 | myeloid cell activation involved in immune response (GO:0002275) | 3.05820675 |
| 79 | response to type I interferon (GO:0034340) | 3.05620891 |
| 80 | type I interferon signaling pathway (GO:0060337) | 3.05238574 |
| 81 | cellular response to type I interferon (GO:0071357) | 3.05238574 |
| 82 | regulation of T cell apoptotic process (GO:0070232) | 3.05103896 |
| 83 | T cell homeostasis (GO:0043029) | 3.04208851 |
| 84 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.03797838 |
| 85 | regulation of T cell chemotaxis (GO:0010819) | 3.03497248 |
| 86 | positive regulation of T cell chemotaxis (GO:0010820) | 3.03497248 |
| 87 | negative regulation of lymphocyte apoptotic process (GO:0070229) | 3.03236973 |
| 88 | lymphocyte costimulation (GO:0031294) | 3.02722222 |
| 89 | regulation of isotype switching to IgG isotypes (GO:0048302) | 2.96929048 |
| 90 | lymphocyte homeostasis (GO:0002260) | 2.96069703 |
| 91 | lymphocyte migration (GO:0072676) | 2.95207320 |
| 92 | negative regulation of adaptive immune response based on somatic recombination of immune receptors b | 2.94918022 |
| 93 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 2.92590376 |
| 94 | negative regulation of adaptive immune response (GO:0002820) | 2.90459636 |
| 95 | regulation of T cell mediated immunity (GO:0002709) | 2.89694917 |
| 96 | regulation of granulocyte differentiation (GO:0030852) | 2.88326093 |
| 97 | regulation of CD4-positive, alpha-beta T cell activation (GO:2000514) | 2.87274016 |
| 98 | regulation of alpha-beta T cell activation (GO:0046634) | 2.86671946 |
| 99 | positive regulation of CD4-positive, alpha-beta T cell activation (GO:2000516) | 2.86637670 |
| 100 | negative regulation of phagocytosis (GO:0050765) | 2.85849813 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 6.18430513 |
| 2 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 5.94339870 |
| 3 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 5.72992574 |
| 4 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 5.38753216 |
| 5 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 4.05861851 |
| 6 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.59481779 |
| 7 | RUNX_20019798_ChIP-Seq_JUKART_Human | 3.50974371 |
| 8 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.39326024 |
| 9 | MYB_26560356_Chip-Seq_TH2_Human | 3.37665206 |
| 10 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.00662724 |
| 11 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.97983980 |
| 12 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.84856769 |
| 13 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.83322395 |
| 14 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.69365583 |
| 15 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.61095209 |
| 16 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 2.57793714 |
| 17 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.56652100 |
| 18 | MYB_26560356_Chip-Seq_TH1_Human | 2.54174745 |
| 19 | GATA3_27048872_Chip-Seq_THYMUS_Human | 2.47119035 |
| 20 | UTX_26944678_Chip-Seq_JUKART_Human | 2.41298320 |
| 21 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.37099436 |
| 22 | MAF_26560356_Chip-Seq_TH1_Human | 2.36646246 |
| 23 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.35743187 |
| 24 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.23520963 |
| 25 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.21719092 |
| 26 | MAF_26560356_Chip-Seq_TH2_Human | 1.99428736 |
| 27 | GATA3_26560356_Chip-Seq_TH2_Human | 1.97965548 |
| 28 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.97777072 |
| 29 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.92726936 |
| 30 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.91584016 |
| 31 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.87715545 |
| 32 | SPI1_23127762_ChIP-Seq_K562_Human | 1.87111483 |
| 33 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.82008728 |
| 34 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.80046766 |
| 35 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.79985004 |
| 36 | MYC_22102868_ChIP-Seq_BL_Human | 1.79935583 |
| 37 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.75756035 |
| 38 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.72139424 |
| 39 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.61551414 |
| 40 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.60706463 |
| 41 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.53881581 |
| 42 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.42707334 |
| 43 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.42491504 |
| 44 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.41949755 |
| 45 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.37930734 |
| 46 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.34828906 |
| 47 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.33726981 |
| 48 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.30447888 |
| 49 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.26995201 |
| 50 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.25649871 |
| 51 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.20461879 |
| 52 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.18308625 |
| 53 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.11538609 |
| 54 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.09920587 |
| 55 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.09598302 |
| 56 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.09377466 |
| 57 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.09046364 |
| 58 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.08246033 |
| 59 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.07701159 |
| 60 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.07508483 |
| 61 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.07293481 |
| 62 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.07221907 |
| 63 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.06869790 |
| 64 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.05484630 |
| 65 | GATA1_22025678_ChIP-Seq_K562_Human | 1.04041066 |
| 66 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.03980066 |
| 67 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.01849052 |
| 68 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.01460673 |
| 69 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.01029809 |
| 70 | PU_27001747_Chip-Seq_BMDM_Mouse | 0.99308173 |
| 71 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.98994341 |
| 72 | TCF7_22412390_ChIP-Seq_EML_Mouse | 0.98135039 |
| 73 | GATA1_19941826_ChIP-Seq_K562_Human | 0.96875905 |
| 74 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.95251025 |
| 75 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.94408470 |
| 76 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.92261438 |
| 77 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 0.91423884 |
| 78 | TAL1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.90625020 |
| 79 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.89090521 |
| 80 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.87745045 |
| 81 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 0.87732455 |
| 82 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.85667578 |
| 83 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.85567417 |
| 84 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.84154753 |
| 85 | GATA2_19941826_ChIP-Seq_K562_Human | 0.84109956 |
| 86 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.81951144 |
| 87 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.80790317 |
| 88 | GATA3_26560356_Chip-Seq_TH1_Human | 0.80675461 |
| 89 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.80285963 |
| 90 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.80089541 |
| 91 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 0.78829794 |
| 92 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 0.78075077 |
| 93 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.77937695 |
| 94 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 0.77191500 |
| 95 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.76641740 |
| 96 | RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.76253760 |
| 97 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.76065795 |
| 98 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.75385856 |
| 99 | P300_27268052_Chip-Seq_Bcells_Human | 0.75247988 |
| 100 | RUNX1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.74523827 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005671_abnormal_response_to | 5.16863162 |
| 2 | MP0001835_abnormal_antigen_presentation | 4.29622559 |
| 3 | MP0003763_abnormal_thymus_physiology | 4.12635802 |
| 4 | MP0003724_increased_susceptibility_to | 3.47456528 |
| 5 | MP0001800_abnormal_humoral_immune | 3.34757789 |
| 6 | MP0000685_abnormal_immune_system | 3.20714013 |
| 7 | MP0005000_abnormal_immune_tolerance | 3.18680480 |
| 8 | MP0005387_immune_system_phenotype | 3.12108865 |
| 9 | MP0001790_abnormal_immune_system | 3.12108865 |
| 10 | MP0009785_altered_susceptibility_to | 3.02702072 |
| 11 | MP0003436_decreased_susceptibility_to | 2.86262595 |
| 12 | MP0002723_abnormal_immune_serum | 2.84885219 |
| 13 | MP0002420_abnormal_adaptive_immunity | 2.81167562 |
| 14 | MP0005025_abnormal_response_to | 2.79098144 |
| 15 | MP0001819_abnormal_immune_cell | 2.74723651 |
| 16 | MP0002452_abnormal_antigen_presenting | 2.59432738 |
| 17 | MP0002148_abnormal_hypersensitivity_rea | 2.57201866 |
| 18 | MP0002166_altered_tumor_susceptibility | 2.52859740 |
| 19 | MP0002419_abnormal_innate_immunity | 2.42568277 |
| 20 | MP0002398_abnormal_bone_marrow | 2.40288294 |
| 21 | MP0002405_respiratory_system_inflammati | 2.33654931 |
| 22 | MP0000703_abnormal_thymus_morphology | 2.28645675 |
| 23 | MP0000716_abnormal_immune_system | 2.25175069 |
| 24 | MP0004947_skin_inflammation | 2.21461494 |
| 25 | MP0009333_abnormal_splenocyte_physiolog | 2.16434883 |
| 26 | MP0004381_abnormal_hair_follicle | 2.13831981 |
| 27 | MP0005464_abnormal_platelet_physiology | 2.06169340 |
| 28 | MP0002722_abnormal_immune_system | 2.04531695 |
| 29 | MP0000689_abnormal_spleen_morphology | 2.04471813 |
| 30 | MP0006082_CNS_inflammation | 2.01826073 |
| 31 | MP0010155_abnormal_intestine_physiology | 1.94396914 |
| 32 | MP0002006_tumorigenesis | 1.86577869 |
| 33 | MP0001845_abnormal_inflammatory_respons | 1.79118775 |
| 34 | MP0003866_abnormal_defecation | 1.79006062 |
| 35 | MP0002429_abnormal_blood_cell | 1.78594372 |
| 36 | MP0002132_abnormal_respiratory_system | 1.77411484 |
| 37 | MP0005075_abnormal_melanosome_morpholog | 1.70394146 |
| 38 | MP0003303_peritoneal_inflammation | 1.70270402 |
| 39 | MP0002933_joint_inflammation | 1.56559873 |
| 40 | MP0001873_stomach_inflammation | 1.54918259 |
| 41 | MP0001533_abnormal_skeleton_physiology | 1.46795251 |
| 42 | MP0001853_heart_inflammation | 1.46307293 |
| 43 | MP0002396_abnormal_hematopoietic_system | 1.42170261 |
| 44 | MP0002138_abnormal_hepatobiliary_system | 1.36099603 |
| 45 | MP0003300_gastrointestinal_ulcer | 1.34273798 |
| 46 | MP0005451_abnormal_body_composition | 1.31692915 |
| 47 | MP0008469_abnormal_protein_level | 1.22568492 |
| 48 | MP0005310_abnormal_salivary_gland | 1.18472722 |
| 49 | MP0009764_decreased_sensitivity_to | 1.18123831 |
| 50 | MP0000569_abnormal_digit_pigmentation | 1.17706259 |
| 51 | MP0002998_abnormal_bone_remodeling | 1.10938762 |
| 52 | MP0000858_altered_metastatic_potential | 1.08360905 |
| 53 | MP0009278_abnormal_bone_marrow | 1.06226445 |
| 54 | MP0003448_altered_tumor_morphology | 1.06155510 |
| 55 | MP0002277_abnormal_respiratory_mucosa | 1.01605234 |
| 56 | MP0000465_gastrointestinal_hemorrhage | 0.98556009 |
| 57 | MP0009763_increased_sensitivity_to | 0.96823509 |
| 58 | MP0008260_abnormal_autophagy | 0.90344596 |
| 59 | MP0003172_abnormal_lysosome_physiology | 0.90117640 |
| 60 | MP0001851_eye_inflammation | 0.87506586 |
| 61 | MP0000015_abnormal_ear_pigmentation | 0.86798219 |
| 62 | MP0002009_preneoplasia | 0.86184782 |
| 63 | MP0002019_abnormal_tumor_incidence | 0.80588593 |
| 64 | MP0003045_fibrosis | 0.79693848 |
| 65 | MP0003183_abnormal_peptide_metabolism | 0.79478799 |
| 66 | MP0003828_pulmonary_edema | 0.76892518 |
| 67 | MP0004147_increased_porphyrin_level | 0.75008872 |
| 68 | MP0005397_hematopoietic_system_phenotyp | 0.71784456 |
| 69 | MP0001545_abnormal_hematopoietic_system | 0.71784456 |
| 70 | MP0005166_decreased_susceptibility_to | 0.69777894 |
| 71 | MP0005174_abnormal_tail_pigmentation | 0.69489408 |
| 72 | MP0001663_abnormal_digestive_system | 0.68022530 |
| 73 | MP0004130_abnormal_muscle_cell | 0.66944197 |
| 74 | MP0003786_premature_aging | 0.65397351 |
| 75 | MP0009765_abnormal_xenobiotic_induced | 0.64502434 |
| 76 | MP0002876_abnormal_thyroid_physiology | 0.63310726 |
| 77 | MP0003656_abnormal_erythrocyte_physiolo | 0.62142544 |
| 78 | MP0004883_abnormal_blood_vessel | 0.59491148 |
| 79 | MP0001501_abnormal_sleep_pattern | 0.58039067 |
| 80 | MP0003806_abnormal_nucleotide_metabolis | 0.57725810 |
| 81 | MP0004808_abnormal_hematopoietic_stem | 0.56993905 |
| 82 | MP0000490_abnormal_crypts_of | 0.56104005 |
| 83 | MP0006035_abnormal_mitochondrial_morpho | 0.55673274 |
| 84 | MP0008877_abnormal_DNA_methylation | 0.55596835 |
| 85 | MP0003795_abnormal_bone_structure | 0.55363703 |
| 86 | MP0000249_abnormal_blood_vessel | 0.54218023 |
| 87 | MP0004510_myositis | 0.53985518 |
| 88 | MP0005390_skeleton_phenotype | 0.53417286 |
| 89 | MP0002877_abnormal_melanocyte_morpholog | 0.53307062 |
| 90 | MP0008873_increased_physiological_sensi | 0.53257779 |
| 91 | MP0003646_muscle_fatigue | 0.52135188 |
| 92 | MP0002136_abnormal_kidney_physiology | 0.48389847 |
| 93 | MP0002693_abnormal_pancreas_physiology | 0.48023057 |
| 94 | MP0005164_abnormal_response_to | 0.47290086 |
| 95 | MP0000920_abnormal_myelination | 0.45150267 |
| 96 | MP0008995_early_reproductive_senescence | 0.44420118 |
| 97 | MP0003075_altered_response_to | 0.43583314 |
| 98 | MP0002095_abnormal_skin_pigmentation | 0.40741225 |
| 99 | MP0003878_abnormal_ear_physiology | 0.40615177 |
| 100 | MP0005377_hearing/vestibular/ear_phenot | 0.40615177 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | T lymphocytopenia (HP:0005403) | 7.18770966 |
| 2 | Abnormality of T cell number (HP:0011839) | 6.44219375 |
| 3 | Severe combined immunodeficiency (HP:0004430) | 6.06204058 |
| 4 | Panhypogammaglobulinemia (HP:0003139) | 5.81550662 |
| 5 | Hypoplasia of the thymus (HP:0000778) | 5.03688767 |
| 6 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.97198868 |
| 7 | Combined immunodeficiency (HP:0005387) | 4.96675170 |
| 8 | Abnormality of T cells (HP:0002843) | 4.94770766 |
| 9 | IgG deficiency (HP:0004315) | 4.87423177 |
| 10 | Recurrent fungal infections (HP:0002841) | 4.73684721 |
| 11 | Thyroiditis (HP:0100646) | 4.58612069 |
| 12 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 4.57768786 |
| 13 | Recurrent viral infections (HP:0004429) | 4.48011089 |
| 14 | Abnormality of eosinophils (HP:0001879) | 4.30279047 |
| 15 | Myositis (HP:0100614) | 4.28208440 |
| 16 | Encephalitis (HP:0002383) | 4.24626328 |
| 17 | Chronic mucocutaneous candidiasis (HP:0002728) | 4.14894075 |
| 18 | Recurrent cutaneous fungal infections (HP:0011370) | 4.14894075 |
| 19 | Eosinophilia (HP:0001880) | 4.10198936 |
| 20 | Meningitis (HP:0001287) | 4.06053740 |
| 21 | B lymphocytopenia (HP:0010976) | 4.00321549 |
| 22 | Granulocytopenia (HP:0001913) | 3.96928481 |
| 23 | Retrobulbar optic neuritis (HP:0100654) | 3.95987346 |
| 24 | Optic neuritis (HP:0100653) | 3.95987346 |
| 25 | Stomatitis (HP:0010280) | 3.95244717 |
| 26 | Abnormality of B cell number (HP:0010975) | 3.88486172 |
| 27 | Hypoproteinemia (HP:0003075) | 3.84035883 |
| 28 | Eczematoid dermatitis (HP:0000976) | 3.73079908 |
| 29 | Orchitis (HP:0100796) | 3.68076968 |
| 30 | Agammaglobulinemia (HP:0004432) | 3.67867564 |
| 31 | Leukocytosis (HP:0001974) | 3.66705455 |
| 32 | Abnormality of macrophages (HP:0004311) | 3.62093510 |
| 33 | Autoimmune hemolytic anemia (HP:0001890) | 3.59148173 |
| 34 | Increased IgM level (HP:0003496) | 3.48701576 |
| 35 | Recurrent bronchitis (HP:0002837) | 3.39902508 |
| 36 | Recurrent bacterial skin infections (HP:0005406) | 3.39611098 |
| 37 | Recurrent abscess formation (HP:0002722) | 3.33881193 |
| 38 | Aplastic anemia (HP:0001915) | 3.26057358 |
| 39 | Abnormality of T cell physiology (HP:0011840) | 3.21866474 |
| 40 | Chronic diarrhea (HP:0002028) | 3.19345645 |
| 41 | Keratoconjunctivitis sicca (HP:0001097) | 3.18365418 |
| 42 | Vasculitis (HP:0002633) | 3.14852038 |
| 43 | Recurrent skin infections (HP:0001581) | 3.13228619 |
| 44 | Mediastinal lymphadenopathy (HP:0100721) | 3.12643968 |
| 45 | IgM deficiency (HP:0002850) | 3.07304444 |
| 46 | Pustule (HP:0200039) | 3.07211655 |
| 47 | Pulmonary infiltrates (HP:0002113) | 3.04640671 |
| 48 | Gastrointestinal infarctions (HP:0005244) | 2.93054278 |
| 49 | Keratoconjunctivitis (HP:0001096) | 2.92184310 |
| 50 | Obstructive lung disease (HP:0006536) | 2.92023495 |
| 51 | Chronic obstructive pulmonary disease (HP:0006510) | 2.92023495 |
| 52 | Lymphopenia (HP:0001888) | 2.82786928 |
| 53 | Spontaneous hematomas (HP:0007420) | 2.78405374 |
| 54 | Inflammation of the large intestine (HP:0002037) | 2.75779803 |
| 55 | Hemoptysis (HP:0002105) | 2.62118740 |
| 56 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.59489341 |
| 57 | Colitis (HP:0002583) | 2.59045226 |
| 58 | Lymphoma (HP:0002665) | 2.58677078 |
| 59 | Gastrointestinal inflammation (HP:0004386) | 2.51491358 |
| 60 | Aplasia/Hypoplasia of the thymus (HP:0010515) | 2.49915480 |
| 61 | Increased IgE level (HP:0003212) | 2.49249454 |
| 62 | Pulmonary embolism (HP:0002204) | 2.49049747 |
| 63 | Joint swelling (HP:0001386) | 2.47738737 |
| 64 | Autoimmune thrombocytopenia (HP:0001973) | 2.42733368 |
| 65 | Hypergammaglobulinemia (HP:0010702) | 2.40093596 |
| 66 | Acute hepatic failure (HP:0006554) | 2.33770172 |
| 67 | Prolonged bleeding time (HP:0003010) | 2.29108647 |
| 68 | Chest pain (HP:0100749) | 2.26313389 |
| 69 | Petechiae (HP:0000967) | 2.23728210 |
| 70 | Abnormality of the prostate (HP:0008775) | 2.21777753 |
| 71 | Gangrene (HP:0100758) | 2.17504736 |
| 72 | Epistaxis (HP:0000421) | 2.15450400 |
| 73 | Arterial thrombosis (HP:0004420) | 2.14235703 |
| 74 | Slow saccadic eye movements (HP:0000514) | 2.13208056 |
| 75 | Abnormality of the pleura (HP:0002103) | 2.12911150 |
| 76 | Anorexia (HP:0002039) | 2.08041437 |
| 77 | Sepsis (HP:0100806) | 2.05435668 |
| 78 | Bronchitis (HP:0012387) | 2.02208321 |
| 79 | Alveolar cell carcinoma (HP:0006519) | 1.99759377 |
| 80 | Purpura (HP:0000979) | 1.96476284 |
| 81 | Chronic otitis media (HP:0000389) | 1.95766225 |
| 82 | Chronic sinusitis (HP:0011109) | 1.95715131 |
| 83 | Basal ganglia calcification (HP:0002135) | 1.95127950 |
| 84 | Urticaria (HP:0001025) | 1.92707312 |
| 85 | Papilledema (HP:0001085) | 1.90032951 |
| 86 | Microcytic anemia (HP:0001935) | 1.87698539 |
| 87 | Verrucae (HP:0200043) | 1.87123594 |
| 88 | Papilloma (HP:0012740) | 1.87123594 |
| 89 | Neoplasm of the tracheobronchial system (HP:0100552) | 1.86780582 |
| 90 | Skin rash (HP:0000988) | 1.86128342 |
| 91 | Abnormality of the thymus (HP:0000777) | 1.85948591 |
| 92 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 1.83909717 |
| 93 | Glomerulopathy (HP:0100820) | 1.82093258 |
| 94 | Gingival bleeding (HP:0000225) | 1.81913738 |
| 95 | Keratitis (HP:0000491) | 1.77601360 |
| 96 | Pulmonary fibrosis (HP:0002206) | 1.76567441 |
| 97 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.75543232 |
| 98 | Episodic fever (HP:0001954) | 1.73440652 |
| 99 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 1.71232793 |
| 100 | Abnormality of glycolipid metabolism (HP:0010969) | 1.71232793 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TXK | 5.27141453 |
| 2 | MAP4K1 | 4.82901215 |
| 3 | RIPK4 | 3.88582155 |
| 4 | FES | 3.31985962 |
| 5 | TAOK3 | 3.19473274 |
| 6 | ZAP70 | 2.53586062 |
| 7 | CSK | 2.38383951 |
| 8 | GRK6 | 2.27937463 |
| 9 | KDR | 2.25797063 |
| 10 | NLK | 2.06755797 |
| 11 | SYK | 2.06600766 |
| 12 | MAP3K14 | 1.98694737 |
| 13 | BTK | 1.97686127 |
| 14 | ITK | 1.89066713 |
| 15 | JAK3 | 1.86987358 |
| 16 | MAP2K3 | 1.72294989 |
| 17 | JAK1 | 1.69483637 |
| 18 | IRAK4 | 1.66480061 |
| 19 | KIT | 1.66186592 |
| 20 | BMPR2 | 1.65978417 |
| 21 | MAPKAPK3 | 1.64920464 |
| 22 | IKBKE | 1.64444493 |
| 23 | LCK | 1.64393023 |
| 24 | BLK | 1.56107042 |
| 25 | IKBKB | 1.41859620 |
| 26 | MAP3K3 | 1.40419130 |
| 27 | TESK2 | 1.39122913 |
| 28 | MAP3K13 | 1.38313600 |
| 29 | HCK | 1.38154606 |
| 30 | TYK2 | 1.34895641 |
| 31 | LYN | 1.32501388 |
| 32 | PRKCQ | 1.30810336 |
| 33 | TNK2 | 1.27106180 |
| 34 | MARK3 | 1.25975816 |
| 35 | MATK | 1.12972320 |
| 36 | GRK7 | 1.12496103 |
| 37 | MAP3K11 | 1.12478169 |
| 38 | ADRBK2 | 1.09596681 |
| 39 | TBK1 | 1.09272671 |
| 40 | MAP3K10 | 1.08776621 |
| 41 | TAOK1 | 1.07668918 |
| 42 | TEC | 1.05235012 |
| 43 | STK10 | 0.97001709 |
| 44 | TLK1 | 0.94980267 |
| 45 | ZAK | 0.93964584 |
| 46 | ERN1 | 0.90514195 |
| 47 | CSF1R | 0.90239311 |
| 48 | PIK3CG | 0.87812661 |
| 49 | FGR | 0.86042638 |
| 50 | MST4 | 0.83737448 |
| 51 | NUAK1 | 0.81296651 |
| 52 | CLK1 | 0.80553198 |
| 53 | EPHB1 | 0.76903858 |
| 54 | JAK2 | 0.75693972 |
| 55 | PIM1 | 0.73116786 |
| 56 | BMPR1B | 0.72290033 |
| 57 | MAPK12 | 0.71248557 |
| 58 | CDK4 | 0.70591148 |
| 59 | MAP3K1 | 0.69350637 |
| 60 | FGFR3 | 0.69072245 |
| 61 | PDK1 | 0.68131895 |
| 62 | SCYL2 | 0.66760066 |
| 63 | FGFR4 | 0.66658509 |
| 64 | TAOK2 | 0.65617375 |
| 65 | MAPK11 | 0.65418042 |
| 66 | TGFBR2 | 0.62205373 |
| 67 | EPHA3 | 0.61446245 |
| 68 | SIK3 | 0.58756560 |
| 69 | CAMKK2 | 0.58447217 |
| 70 | FYN | 0.56137766 |
| 71 | MAP3K5 | 0.55352314 |
| 72 | TYRO3 | 0.55027104 |
| 73 | PRPF4B | 0.54189030 |
| 74 | MAP2K6 | 0.52713744 |
| 75 | NEK6 | 0.52244699 |
| 76 | PDGFRB | 0.51086128 |
| 77 | BCKDK | 0.49447873 |
| 78 | RPS6KA4 | 0.47775186 |
| 79 | MAPKAPK2 | 0.45841337 |
| 80 | PTK2B | 0.44135286 |
| 81 | HIPK2 | 0.43782748 |
| 82 | TRPM7 | 0.41737208 |
| 83 | MAPK7 | 0.40808731 |
| 84 | CDK6 | 0.39607948 |
| 85 | DAPK1 | 0.38194858 |
| 86 | MUSK | 0.35928174 |
| 87 | CHUK | 0.35467839 |
| 88 | STK38 | 0.34562056 |
| 89 | SGK2 | 0.34001490 |
| 90 | LRRK2 | 0.31101330 |
| 91 | EIF2AK3 | 0.30851591 |
| 92 | GRK5 | 0.29953581 |
| 93 | FRK | 0.29816408 |
| 94 | INSR | 0.29723504 |
| 95 | TGFBR1 | 0.28428592 |
| 96 | STK4 | 0.28197781 |
| 97 | IGF1R | 0.27829814 |
| 98 | PINK1 | 0.25398580 |
| 99 | IRAK1 | 0.24366584 |
| 100 | SGK3 | 0.21593875 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary immunodeficiency_Homo sapiens_hsa05340 | 5.69357278 |
| 2 | Graft-versus-host disease_Homo sapiens_hsa05332 | 3.53809394 |
| 3 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 3.43762056 |
| 4 | Allograft rejection_Homo sapiens_hsa05330 | 3.23154896 |
| 5 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 3.17921951 |
| 6 | Antigen processing and presentation_Homo sapiens_hsa04612 | 3.17785309 |
| 7 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 2.99725880 |
| 8 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.53818523 |
| 9 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 2.52936839 |
| 10 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.34666919 |
| 11 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.31268888 |
| 12 | Measles_Homo sapiens_hsa05162 | 2.25870507 |
| 13 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.25177082 |
| 14 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.09131411 |
| 15 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.03873713 |
| 16 | Leishmaniasis_Homo sapiens_hsa05140 | 2.02627936 |
| 17 | Asthma_Homo sapiens_hsa05310 | 1.99086507 |
| 18 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.91828420 |
| 19 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.74195795 |
| 20 | Malaria_Homo sapiens_hsa05144 | 1.71356436 |
| 21 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.69914321 |
| 22 | Viral myocarditis_Homo sapiens_hsa05416 | 1.63665027 |
| 23 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.59705470 |
| 24 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.57850091 |
| 25 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.53285235 |
| 26 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.51891552 |
| 27 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.46508867 |
| 28 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.42823924 |
| 29 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.39398736 |
| 30 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.34598412 |
| 31 | Tuberculosis_Homo sapiens_hsa05152 | 1.33246095 |
| 32 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.29031163 |
| 33 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.28612012 |
| 34 | Shigellosis_Homo sapiens_hsa05131 | 1.17424301 |
| 35 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.10624312 |
| 36 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.06347836 |
| 37 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.03667097 |
| 38 | Influenza A_Homo sapiens_hsa05164 | 1.03433118 |
| 39 | Apoptosis_Homo sapiens_hsa04210 | 1.01731106 |
| 40 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.97926032 |
| 41 | Platelet activation_Homo sapiens_hsa04611 | 0.96965278 |
| 42 | Hepatitis B_Homo sapiens_hsa05161 | 0.84753716 |
| 43 | Legionellosis_Homo sapiens_hsa05134 | 0.84010390 |
| 44 | Salmonella infection_Homo sapiens_hsa05132 | 0.78646660 |
| 45 | HTLV-I infection_Homo sapiens_hsa05166 | 0.76843011 |
| 46 | Pertussis_Homo sapiens_hsa05133 | 0.74864101 |
| 47 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.71472252 |
| 48 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.71436275 |
| 49 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.71268647 |
| 50 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.67358492 |
| 51 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.64082869 |
| 52 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.63996065 |
| 53 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.63973922 |
| 54 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.61426094 |
| 55 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.59788728 |
| 56 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.58938103 |
| 57 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.58278536 |
| 58 | Olfactory transduction_Homo sapiens_hsa04740 | 0.58257925 |
| 59 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.58018494 |
| 60 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.57928535 |
| 61 | Hepatitis C_Homo sapiens_hsa05160 | 0.54248265 |
| 62 | Phagosome_Homo sapiens_hsa04145 | 0.51799507 |
| 63 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.51706034 |
| 64 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.47153025 |
| 65 | Other glycan degradation_Homo sapiens_hsa00511 | 0.44083986 |
| 66 | Endocytosis_Homo sapiens_hsa04144 | 0.43201632 |
| 67 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.41879444 |
| 68 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.41275394 |
| 69 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.40560378 |
| 70 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.40467492 |
| 71 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.39028103 |
| 72 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.36453537 |
| 73 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.35190751 |
| 74 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.33833528 |
| 75 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.33511012 |
| 76 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.31793621 |
| 77 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.31332226 |
| 78 | Proteasome_Homo sapiens_hsa03050 | 0.31088830 |
| 79 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.30661167 |
| 80 | Lysosome_Homo sapiens_hsa04142 | 0.27417554 |
| 81 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.25686684 |
| 82 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.24891996 |
| 83 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.23007359 |
| 84 | Insulin resistance_Homo sapiens_hsa04931 | 0.22452826 |
| 85 | Phototransduction_Homo sapiens_hsa04744 | 0.19758400 |
| 86 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.19204319 |
| 87 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.18340238 |
| 88 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.15619788 |
| 89 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.14667257 |
| 90 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.14077986 |
| 91 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.13824841 |
| 92 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.12898560 |
| 93 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.10719100 |
| 94 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.10330800 |
| 95 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.09817470 |
| 96 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.08777761 |
| 97 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.07969331 |
| 98 | Long-term potentiation_Homo sapiens_hsa04720 | 0.07347175 |
| 99 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.06929394 |
| 100 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.06020380 |

